当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析 - 现金流量表

海昇药业

(920656)

  

流通市值:5.96亿  总市值:18.40亿
流通股本:3237.63万   总股本:1.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金91,582,662.6847,696,273.2226,047,046.76121,953,870.98
  收到其他与经营活动有关的现金8,052,732.73982,729.48363,280.8216,879,219.91
  经营活动现金流入小计99,635,395.4148,679,002.726,410,327.58138,833,090.89
  购买商品、接受劳务支付的现金37,543,157.6223,942,331.9712,863,484.0856,358,653.01
  支付给职工以及为职工支付的现金23,984,085.9615,865,989.377,473,422.4532,108,308.52
  支付的各项税费13,715,871.368,636,191.514,891,314.6410,621,251.62
  支付其他与经营活动有关的现金5,462,383.63,715,583.422,233,122.7315,091,690.03
  经营活动现金流出小计80,705,498.5452,160,096.2727,461,343.9114,179,903.18
  经营活动产生的现金流量净额18,929,896.87-3,481,093.57-1,051,016.3224,653,187.71
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,111,195.972,713,798.711,573,001.464,877,691.2
  收到的其他与投资活动有关的现金1,831,000,0001,636,000,0001,048,400,0001,830,550,000
  投资活动现金流入小计1,834,111,195.971,638,713,798.711,049,973,001.461,835,427,691.2
  购建固定资产、无形资产和其他长期资产支付的现金11,265,115.097,164,144.728,460,216.0723,749,947.16
  支付其他与投资活动有关的现金2,191,000,0001,791,000,0001,118,400,0001,830,550,000
  投资活动现金流出小计2,202,265,115.091,798,164,144.721,126,860,216.071,854,299,947.16
  投资活动产生的现金流量净额-368,153,919.12-159,450,346.01-76,887,214.61-18,872,255.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金---367,150,000
  收到其他与筹资活动有关的现金---19,698,100
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---386,848,100
  分配股利、利润或偿付利息支付的现金20,000,00020,000,000-40,000,000
  支付其他与筹资活动有关的现金19,698,1009,798,100-6,300,600
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计39,698,10029,798,100-46,300,600
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-39,698,100-29,798,100-340,547,500
四、汇率变动对现金及现金等价物的影响-36,256.69104,897.98141,1001,225,349.33
五、现金及现金等价物净增加额-388,958,378.94-192,624,641.6-77,797,130.93347,553,781.08
  加:期初现金及现金等价物余额446,644,080.49446,644,080.49446,853,145.5199,090,299.41
  期末现金及现金等价物余额57,685,701.55254,019,438.89369,056,014.58446,644,080.49
补充资料:
  净利润-30,325,906.98-50,750,223.4
  资产减值准备-5,028.7-371,424.8
  固定资产和投资性房地产折旧-8,330,573.95-10,379,238.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-8,330,573.95-10,379,238.96
  无形资产摊销-414,674.46-691,864.68
  长期待摊费用摊销-88,225.02-168,020.6
  财务费用--43,864.99--1,225,349.33
  投资损失--2,713,798.71--4,877,691.2
  递延所得税--132,367.94-51,153.37
  其中:递延所得税资产减少--132,367.94-51,153.37
  存货的减少--4,837,487.71-3,823,109.75
  经营性应收项目的减少--13,277,196.6--35,838,322.45
  经营性应付项目的增加--23,624,858.46-36,485.41
  其他-1,106,647.52-1,035,476.99
  现金的期末余额-254,019,438.89-446,644,080.49
  减:现金的期初余额-446,644,080.49-99,090,299.41
  现金及现金等价物的净增加额--192,624,641.6-347,553,781.08
公告日期2025-10-272025-08-212025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑